Intellia shareholders approve officer liability limitation, re-elect directors at annual meeting

Intellia Therapeutics, Inc.

Stockholders approved amendment limiting officer liability under DGCL; 69M for, 2.9M against.
Fred Cohen and Frank Verwiel re-elected as Class II directors with 65.4M and 55.8M votes for, respectively.
Deloitte & Touche ratified as auditor for FY2024; 83.5M for, 256.7K against.
Say-on-pay proposal passed with 70.4M for, 1.5M against.
Certificate of Second Amendment filed with Delaware Secretary of State on June 12, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.